Mereo BioPharma Group plc (MREO)

Satixfy Communications Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	62.48	69.8	57.42	68.18	126.91	31.3
Short-Term Investments	-	-	-	-	0.77	0.75
Cash & Short-Term Investments	62.48	69.8	57.42	68.18	127.68	32.04
Cash Growth	28.41%	21.56%	-15.78%	-46.60%	298.48%	48.00%
Other Receivables	2.4	2.79	3.13	2.31	2.46	5.78
Receivables	2.4	2.79	3.13	2.31	2.46	5.78
Prepaid Expenses	1.64	0.33	0.97	3.78	3.79	2.21
Other Current Assets	0.38	1.85	2.23	0.92	0.55	0.56
Total Current Assets	66.9	74.76	63.76	75.2	134.49	40.58
Property, Plant & Equipment	0.87	0.98	1.65	2.22	3.43	2.15
Other Intangible Assets	0.55	0.64	1.09	-	33.26	43.21
Total Assets	68.32	76.39	66.5	77.41	171.18	85.94
Accounts Payable	3.16	2.68	2.35	3.49	3.09	4.32
Accrued Expenses	3.22	4.57	5.75	5.64	5.44	5.9
Current Portion of Long-Term Debt	-	5.54	-	13.33	-	-
Current Portion of Leases	0.75	0.71	0.65	0.56	0.84	0.87
Current Income Taxes Payable	-	-	-	-	2.06	-
Other Current Liabilities	0.37	0.36	0.74	1.36	5.55	0.6
Total Current Liabilities	7.5	13.85	9.49	24.38	16.98	11.69
Long-Term Debt	-	-	4.39	-	19.48	22.04
Long-Term Leases	-	0.19	0.91	1.48	2.38	1.58
Other Long-Term Liabilities	0.74	1.39	1.18	0.16	13.18	71.07
Total Liabilities	8.24	15.42	15.96	26.01	52.02	106.38
Common Stock	3.13	3.06	2.78	2.48	2.38	1.39
Additional Paid-In Capital	544.27	539.64	486.11	476.52	335.08	220.88
Retained Earnings	-472.03	-462.88	-419.63	-404.58	-402.11	-422.82
Treasury Stock	-	-	-1.23	-1.34	-	-
Comprehensive Income & Other	-15.29	-18.85	-17.49	-21.69	183.82	180.11
Shareholders' Equity	60.08	60.97	50.54	51.4	119.16	-20.44
Total Liabilities & Equity	68.32	76.39	66.5	77.41	171.18	85.94
Total Debt	0.75	6.43	5.95	15.37	22.69	24.49
Net Cash (Debt)	61.74	63.37	51.47	52.81	104.99	7.55
Net Cash Growth	44.78%	23.13%	-2.54%	-49.70%	1289.80%	-
Net Cash Per Share	0.41	0.43	0.39	0.44	0.95	0.11
Filing Date Shares Outstanding	159	159	140.01	124.74	116.73	108
Total Common Shares Outstanding	159	155.15	140	124.74	116.73	67.54
Working Capital	59.4	60.92	54.27	50.82	117.51	28.89
Book Value Per Share	0.38	0.39	0.36	0.41	1.02	-0.30
Tangible Book Value	59.53	60.33	49.45	51.4	85.9	-63.65
Tangible Book Value Per Share	0.37	0.39	0.35	0.41	0.74	-0.94
Machinery	0.53	0.49	0.5	0.61	0.48	0.28
Leasehold Improvements	0.74	0.71	0.71	0.68	0.75	0.22

Updated Mar 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q